资金周报｜资金布局低位稀缺品种，中药ETF(159647)获连续22天净流入（10/13-10/17）

Market Overview - The total scale of equity ETFs in the market reached 46,918.32 billion yuan, with a decrease of 761.24 billion yuan in total scale over the past week and a net inflow of 700.48 billion yuan [1] - Industry and thematic ETFs saw a net inflow of 465.43 billion yuan, primarily driven by inflows into the non-bank financial sector, while broad-based and strategic ETFs experienced a net outflow of 142.98 billion yuan [1] Fund Positioning - In the broad-based and strategic ETF segment, the top three inflow sectors were strategy-dividend, Sci-Tech 200, and Sci-Tech 50, while the top three outflow sectors were CSI A500, ChiNext, and CSI 500 [2] - For industry and thematic ETFs, the top five inflow sectors were non-bank financial, banking, semiconductor chips, rare earths, and non-ferrous metals, while the top five outflow sectors were telecommunications, chemicals, pan-pharmaceuticals, consumer electronics, and financial technology [2] Key Focus Areas 1. The leading securities ETF (159993) received a net inflow of 95 million yuan, indicating investor interest despite market conditions. The Shanghai Stock Exchange aims to enhance the quality of listed companies and attract long-term capital [4] 2. The Chinese herbal medicine ETF (159647) has seen continuous net inflows for 22 days, reflecting investor confidence in the sector, particularly following the announcement of a new drug entering clinical trials [5] 3. Institutional funds are at historically low equity positions, suggesting significant potential for future market entry, supported by ongoing capital market reforms and positive signals from US-China negotiations [4]